Avidity Biosciences Cash from Financing (TTM) Insights

Avidity Biosciences Inc (RNA)

25.81 +1.67 (+6.92%) USD | NASDAQ | May 01, 16:00

25.81 0.00 (0.00%) After-Hours: 18:06

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	93.86M
September 30, 2023	305.63M
June 30, 2023	345.21M
March 31, 2023	345.02M
December 31, 2022	346.17M
September 30, 2022	123.23M
June 30, 2022	238.78M
March 31, 2022	200.41M
December 31, 2021	176.32M

Date	Value
September 30, 2021	156.05M
June 30, 2021	-0.466M
March 31, 2021	270.73M
December 31, 2020	272.04M
September 30, 2020	343.41M
June 30, 2020	344.04M
March 31, 2020	86.73M
December 31, 2019	89.23M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.466M

Minimum

Jun 2021

346.17M

Maximum

Dec 2022

219.79M

Average

238.78M

Median

Jun 2022

Cash from Financing (TTM) Benchmarks